Navigation Links
University Hospitals Case Medical Center unlocks mystery of dystonia with advanced imaging
Date:11/14/2011

CLEVELAND -- An estimated 300,000 people in North America are afflicted with dystonia, a disorder characterized by a progressive loss of motor control. Patients with generalized dystonia grapple with involuntary muscle spasms that lead to uncontrolled twisting and turning in awkward, sometimes painful postures. Although cognition, intelligence and life span are often normal, the disorder can have a devastating impact on quality of life, as its victims frequently struggle to perform simple activities of daily living.

At University Hospitals (UH) Case Medical Center's Neurological Institute, a research team is using advanced imaging technology to explore the complex network of brain activity relating to movement in healthy subjects and in patients with dystonia. "Normally, MRI is used to provide an image of the structure of the brain," says Benjamin L. Walter, MD, Medical Director, Deep Brain Stimulation Program, UH Case Medical Center, and Assistant Professor of Neurology, Case Western Reserve University School of Medicine. "Functional MRI [fMRI] takes advantage of the artifact that's created by blood flow and the oxygenation of blood. The level of oxygenation is highly correlated with neural activity in the same regions, so we can see which parts of the brain are being used."

Dr. Walter's current research explores two key areas: the nature of brain activity in patients with dystonia, and how that differs from activity in normal subjects; and understanding how deep brain stimulation (DBS), a leading-edge treatment for selected dystonia patients, works to quiet the involuntary spasms. Treating dystonia with DBS involves the placement of electrodes in the internal segment of the globus pallidus, a subcortical structure also targeted in the DBS treatment of Parkinson's disease, essential tremor and obsessive compulsive disorder. "In disorders such as Parkinson's and essential tremor, when you turn the stimulator on there's a pretty quick benefit," Dr. Walter explains. "That's not the case with dystonia it slowly improves over a long period of time, six months or longer. So there's more of a neuroplastic effect that's probably involved in the mechanism of DBS."

The initial stage of Dr. Walter's research involves using fMRI to observe brain activity in healthy subjects and in patients with dystonia who have not received DBS implants.

"We're looking to examine how sensory and motor information is handled in the brain in patients with dystonia. Dystonia is obviously a movement disorder, but there's a lot of evidence that the integration of sensorimotor information is dysfunctional."

The research team chose to study their subjects' proprioception the sense of how their own limbs are oriented in space "because that's very close to movement, and you get direct feedback about joint position when you move a limb."

Using a small device that vibrates over a wrist tendon, the researchers induce a movement illusion (the false perception that the subject's wrist is flexing) and examine the resulting fMRI images.

"In our normal patients, we're seeing that the motor cortex and the motor portion of the basal ganglia and the posterior striatum are involved," Dr. Walter notes. "In our dystonic patients, we'll look for changes in how the proprioceptive input is being handled. We're hoping to discover where the signal is becoming abnormal in these patients, whether there are different anatomical structures involved, and whether there's a different place we could put the DBS wire and get a more robust effect."

The next stage of the research will include fMRI imaging of patients who have received DBS treatment. "DBS is not really well understood," Dr. Walter says "In part you need to know where to look, and this type of neuroimaging can tell us where there are abnormal hot nodes that are involved in our proprioception paradigm and may be worth investigating using other methods. Essentially, we're defining the differences between dystonia and normal patients, and in the dystonia patients who get DBS, we'll be looking for changes in their brain activity over time, as the dystonia melts away."


'/>"/>

Contact: George Stamatis
george.stamatis@uhhospitals.org
216-844-3667
University Hospitals Case Medical Center
Source:Eurekalert

Related biology news :

1. University of Houston physicist part of major solar energy research team
2. UHN, University of Toronto launch Techna innovation hub to get health technologies to patients faster
3. Tufts University researcher develops living tissue
4. University of Saskatchewan, Royal Ontario Museum researchers track half-billion year old predator
5. Syracuse University receives $2 million from NSF
6. University of Warwick research promises 5-fold reduction in footrot among sheep
7. Science in the liberal arts university
8. NIH training grant awarded to Boston University School of Medicine and College of Engineering
9. $10 million grant supports biological sciences team at University of Nevada, Reno
10. New drug target for Alzheimers, stroke is discovered by University at Buffalo scientists
11. National Science Foundation selects University of Colorado Denver team to study city sustainability
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/19/2016)... , UAE, April 20, 2016 ... be implemented as a compact web-based "all-in-one" system solution ... the biometric fingerprint reader or the door interface with ... of modern access control systems. The minimal dimensions of ... ID readers into the building installations offer considerable freedom ...
(Date:4/14/2016)... 14, 2016 BioCatch ™, ... today announced the appointment of Eyal Goldwerger ... Goldwerger,s leadership appointment comes at a time ... the deployment of its platform at several of the ... which discerns unique cognitive and physiological factors, is a ...
(Date:3/31/2016)... March 31, 2016  Genomics firm Nabsys has completed ... Barrett Bready , M.D., who returned to the ... original technical leadership team, including Chief Technology Officer, ... Development, Steve Nurnberg and Vice President of Software and ... company. Dr. Bready served as CEO of ...
Breaking Biology News(10 mins):
(Date:6/23/2016)... , June 23, 2016   Boston Biomedical ... novel compounds designed to target cancer stemness pathways, ... been granted Orphan Drug Designation from the U.S. ... of gastric cancer, including gastroesophageal junction (GEJ) cancer. ... designed to inhibit cancer stemness pathways by targeting ...
(Date:6/23/2016)... Prostate Cancer Foundation (PCF) is pleased to announce 24 new Young ... cancer. Members of the Class of 2016 were selected from a pool of ... More About the Class of 2016 PCF Young Investigators ... ... ...
(Date:6/23/2016)... , ... June 23, 2016 , ... In a new ... in Denmark detail how a patient who developed lymphedema after being treated for breast ... results could change the paradigm for dealing with this debilitating, frequent side effect of ...
(Date:6/23/2016)... ... 23, 2016 , ... ClinCapture, the only free validated electronic ... showcase its product’s latest features from June 26 to June 30, 2016 for ... Disrupting Clinical Trials in The Cloud during the conference. DIA (Drug Information ...
Breaking Biology Technology: